InvestorsHub Logo
Followers 22
Posts 3636
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Saturday, 02/03/2024 8:57:51 AM

Saturday, February 03, 2024 8:57:51 AM

Post# of 167
Collegium Pharmaceutical (NASDAQ:COLL) Given “Buy” Rating at Needham & Company LLC
Posted by Defense World Staff on Feb 3rd, 2024

Needham & Company LLC reiterated their buy rating on shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) in a report released on Friday morning, Benzinga reports. They currently have a $40.00 target price on the specialty pharmaceutical company’s stock.

https://www.defenseworld.net/2024/02/03/collegium-pharmaceutical-nasdaqcoll-given-buy-rating-at-needham-company-llc.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent COLL News